Publications & Press

Tanić et al. Nature Biotechnology 2022

M Tanić, I. Moghul, S. Rodney, P. Dhami, H. Vaikkinen, J. Ambrose, J. Barrett, A. Feber, S. Beck. Performance comparison and in-silico harmonisation of commercial platforms for DNA methylome analysis by targeted bisulfite sequencing. Nature Biotechnology 2022. https://doi.org/10.1038/s41587-022-01336-9

Read More »

Cavic et al. Oncology, 2022

Cavic M, Kovacevic T, Zaric B, Stojiljkovic D, Jovanovic Korda N, Rancic M, Jankovic R, Radosavljevic D, Stojanovic G, Spasic J. Lung Cancer in Serbia. Journal of Thoracic Oncology. 2022, 17(7): 867-872. https://doi.org/10.1016/j.jtho.2022.04.010

Read More »

Jokic et al. Expert Review of Anticancer Therapy, 2021

Jokic V, Savic-Vujovic K, Spasic J, Marinkovic M, Stanic N, Radosavljevic D, Cavic M. Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity. Expert Review of Anticancer Therapy. 2021. https://www.tandfonline.com/doi/full/10.1080/14737140.2021.1893694

Read More »

Marinkovic M et al. Biomed Research International, 2022

Marinkovic M, Popovic M, Stojanovic-Rundic S, Nikolic M, Cavic M, Gavrilovic D, Teodorovic D, Mitrovic D, Mijatovic Teodorovic Lj. Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients. Biomed Research International. 2022, 2022:7943609. https://doi.org/10.1155/2022/7943609.  

Read More »

Jokic et al. Dose Response, 2022

Jokic V, Savic-Vujovic K, Spasic J, Bukumiric Z, Marinkovic M, Radosavljevic D, Cavic M. Evaluation of Clinical and Genetic Determinants of Treatment Outcome in EGFR Mutation Positive Advanced Lung Adenocarcinoma. Dose Response, 2022 Aug 4;20(3):15593258221117354. doi: 10.1177/15593258221117354.

Read More »
Press

Participation at the IASLC 2022 WCLC World Conference on Lung Cancer

TRACEPIGEN participant Milena Cavic attended the World Lung Cancer Congress (WCLC22) organized by the International Association for the Study of Lung Cancer (IASLC) in Vienna, Austria, August 5-9, 2022. WCLC22 is traditionally the world’s largest international gathering of clinicians, researchers and scientists in the field of lung cancer and thoracic oncology. The congress covered a

Read More »
At the laboratory
Press

Visit to the UCL Cancer Institute

As part of the TRACEPIGEN project, Dr Ivana Boljević spent two weeks in July on a short-stay secondment at UCL Cancer Institute, Department of Cancer Biology, Medical Genomics group (London, UK). She was hosted by Prof Stephan Beck and Dr Nnenna Kannu. During this period, she gained insights into the ongoing projects at the UCL,

Read More »
Lungs with cancerous changes floating inside jar with formaldehyde in morgue
Press

Lung cancer in Serbia

Lung cancer in Serbia Scientists at IORS, supported by the Science Fund of the Republic of Serbia, in collaboration with the Institute for Pulmonary Diseases of Vojvodina and the Pulmonary Diseases Clinic, University Clinical Center Nis have provided an up-to-date overview of the current epidemiological situation concerning lung cancer in Serbia published by Cavic et al.

Read More »
Press

The right tool for the job: Benchmarking kits for DNA methylome analysis

Scientists at IORS, supported by the Science Fund of the Republic of Serbia, in collaboration with Beck lab at UCL Cancer Institute have performed a systematic benchmarking of sequencing-based methods for measuring DNA methylation and developed a framework for data integration across different platforms in a paper published by Tanić et al. in Nature Biotechnology. Epigenetics

Read More »
Press

Liquid Biopsy Training School

Training school for circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) was held on March 28-30, 2022, at Aarhus University Hospital in Denmark. It was co-organized by TRANSCOLONCAN COST Action together with DCCC Danish Research Center for ctDNA, TRACEPIGEN (Science Fund of the Republic of Serbia), and the European Liquid Biopsies Academy- ELBA. TRACEPIGEN

Read More »
Scroll to Top